ANTERIS TECHNOLOGIES GLOBAL CORP. (AVR)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

AVR

AVR - ANTERIS TECHNOLOGIES GLOBAL CORP.

FNArena Sector : NONE
Year End: December
GICS Industry Group : Consumer Durables & Apparel
Debt/EBITDA: -0.02
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$6.80

05 Jun
2025

0.350

OPEN

$6.74

5.43%

HIGH

$6.98

12,029

LOW

$6.48

TARGET
$15.00 120.6% upside
FNARENA'S MARKET CONSENSUS FORECASTS
AVR: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx - 321.8 - 247.7 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A N/A xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 N/A

Estimated Dividend Growth
(Average Of Past Three Years)

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 20232024
EPS Basic xxx-321.8
DPS All xxx0.0
Sales/Revenue xxx4.1 M
Book Value Per Share xxx282.0
Net Operating Cash Flow xxx-92.8 M
Net Profit Margin xxx-2,822.46 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 20232024
Return on Capital Employed xxx-178.42 %
Return on Invested Capital xxx-174.99 %
Return on Assets xxx-132.13 %
Return on Equity xxx-178.42 %
Return on Total Capital xxx-177.79 %
Free Cash Flow ex dividends xxx-96.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 20232024
Short-Term Debt xxx1 M
Long Term Debt xxx1 M
Total Debt xxx2 M
Goodwill - Gross xxx-
Cash & Equivalents - Generic xxx114 M
Price To Book Value xxx-

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 20232024
Capex xxx3.5 M
Capex % of Sales xxx84.35 %
Cost of Goods Sold xxx4 M
Selling, General & Admin. Exp & Other xxx118 M
Research & Development xxx78 M
Investments - Total xxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

25/03/2025

1

Speculative Buy

$15.00

120.59%

Bell Potter notes Anteris Technologies has announced its one-year safety and efficacy data for aortic stenosis patients treated with DurAVR.

The broker views the data as indicative of future outcomes from an approval study for DurAVR, which has the potential to compete with the Sapien valve that continues to dominate the US market with an estimated 65–70% market share.

Bell Potter believes the data have vindicated "superior" patient outcomes compared to Sapien, subject to further studies.

No change to Speculative Buy rating and $15 target price.

FORECAST
Bell Potter forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -247.70 cents.
Bell Potter forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -212.70 cents.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

AVR STOCK CHART

FNArena News on AVR

1
Next Week At A Glance – 29 Jul-2 Aug 2024

Jul 26 2024 - Weekly Reports